Trials / Completed
CompletedNCT00184912
The Effect of Caffeine on Ischemic Preconditioning
Caffeine Reduces Acute Ischemic Preconditioning
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Ischaemic preconditioning (IP) describes the phenomenon that brief periods of ischaemia render the (myocardial) muscle more resistant to a subsequent more prolonged period of ischaemia and reperfusion. Animal studies have provided evidence that adenosine receptor stimulation is an important mediator of IP. As caffeine is an effective adenosine receptor antagonist already at concentrations reached after regular coffee consumption, we aimed to assess whether caffeine impairs IP in humans in vivo. We used a novel and well-validated model to study IP in humans: 99m-Tc-annexin A5 scintigraphy in forearm skeletal muscle. 24 healthy volunteers were randomly assigned to either caffeine (4 mg/kg/iv in 10 minutes) or saline before a protocol for IP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | caffeine | |
| DRUG | Technetium-TC99m-labeled Annexin A5 | |
| PROCEDURE | ten minutes forearm ischemia | |
| PROCEDURE | ischemic forearm exercise |
Timeline
- Start date
- 2003-09-01
- Completion
- 2006-01-01
- First posted
- 2005-09-16
- Last updated
- 2006-11-29
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00184912. Inclusion in this directory is not an endorsement.